Fortress Biotech, Inc. (FBIO) Depreciation USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Fortress Biotech, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2024.
  • Fortress Biotech, Inc. Depreciation for the quarter ending March 31, 2024 was $377 K, a 55.3% decline year-over-year.
  • Fortress Biotech, Inc. Depreciation for the twelve months ending March 31, 2024 was $1.76 M, a 45.1% decline year-over-year.
  • Fortress Biotech, Inc. annual Depreciation for 2023 was $2.23 M, a 28.3% decline from 2022.
  • Fortress Biotech, Inc. annual Depreciation for 2022 was $3.11 M, a 18.3% increase from 2021.
  • Fortress Biotech, Inc. annual Depreciation for 2021 was $2.63 M, a 15.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.76 M $377 K -$467 K -55.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.23 M $186 K -$584 K -75.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $2.81 M $400 K -$400 K -50% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.21 M $800 K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $3.21 M $844 K +$105 K +14.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.11 M $770 K +$45 K +6.21% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $3.06 M $800 K +$100 K +14.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.96 M $800 K +$200 K +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.76 M $739 K +$136 K +22.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.63 M $725 K +$172 K +31.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.46 M $700 K +$100 K +16.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.36 M $600 K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.36 M $603 K +$76 K +14.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.28 M $553 K +$112 K +25.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $2.17 M $600 K +$100 K +20% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.07 M $600 K +$100 K +20% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $1.97 M $527 K +$46 K +9.56% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $1.92 M $441 K -$56 K -11.3% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $1.98 M $500 K +$100 K +25% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.88 M $500 K +$200 K +66.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.68 M $481 K +$285 K +145% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1.39 M $497 K +$425 K +590% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $968 K $400 K +$200 K +100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $768 K $300 K +$120 K +66.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $648 K $196 K -$78 K -28.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $726 K $72 K -$42 K -36.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $768 K $200 K $0 0% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $768 K $180 K +$98 K +120% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $670 K $274 K +$270 K +6750% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $400 K $114 K +$105 K +1167% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $295 K $200 K +$194 K +3233% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $101 K $82 K +$77 K +1540% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $24 K $4 K -$2 K -33.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $26 K $9 K +$3 K +50% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $23 K $6 K $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $23 K $5 K -$1 K -16.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $24 K $6 K +$1 K +20% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $23 K $6 K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $6 K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $6 K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $5 K +$2 K +66.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $3 K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2011 $2 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.